CellaVision AB (publ) (OTCMKTS:CLVSF) Sees Large Growth in Short Interest

CellaVision AB (publ) (OTCMKTS:CLVSF) was the target of a significant growth in short interest in February. As of February 28th, there was short interest totalling 500 shares, a growth of 400.0% from the February 13th total of 100 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 5.0 days.

CellaVision AB (publ) Stock Performance

CLVSF stock opened at $19.28 on Thursday. The company’s 50-day simple moving average is $19.47 and its 200 day simple moving average is $22.86. CellaVision AB has a 52 week low of $19.28 and a 52 week high of $19.91.

About CellaVision AB (publ)

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.